| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |